Posted by Michael Wonder on 01 Feb 2017
Advanced ovarian cancer treatment placed on the PBS, a move praised by doctors and patients
1 January 2017 - Women with advanced ovarian cancer can now pay significantly less for a groundbreaking drug, in a move that has been hailed as the biggest development in the treatment of the disease in 30 years.
The cost of a month of treatment of Lynparza, also known as olaparib, fell from $2250 to $38 as it was added to the Commonwealth-funded Pharmaceutical Benefits Scheme on Wednesday.
